首页|格列齐特缓释片的剂量倾泻研究

格列齐特缓释片的剂量倾泻研究

扫码查看
通过在0.1 mol/L盐酸中添加不同浓度乙醇和提高转速2种方法,评估格列齐特(1)缓释片自制制剂和参比制剂发生剂量倾泻的风险.采用HPLC法进行检测,并对检测方法进行了方法学验证.研究结果显示,参比制剂与自制制剂在加入不同浓度乙醇的盐酸及提高转速后的释放行为基本一致,相似因子(f2)均大于50,且均无剂量倾泻现象.此外,1在含乙醇的盐酸中降解非常迅速,1h降解约40%,产生杂质A和杂质C,且杂质含量己远超质量标准规定的可接受限度,应引起重视.在服用1缓释片时应禁止饮酒,避免因杂质超标而增加未知的安全风险.
Dose Dumping Study of Gliclazide Sustained-release Tablets
By adding different volume fractions of ethanol into 0.1 mol/L hydrochloric acid and increasing the rotational speed,the risk of dose dumping of gliclazide(1)sustained-release tablets(self-made and reference preparations)was evaluated by HPLC,and the detection method was validated.The results showed that the release behavior of the reference preparation and the self-made tablets was basically the same after adding different volume fractions of ethanol in hydrochloric acid and increasing the rotational speed.The similarity factor(f2)values were all greater than 50,and there was no dose dumping phenomenon.This study also found that 1 degraded very rapidly in the hydrochloric acid containing ethanol,with the degradation rate of about 40%in one hour,resulting in impurity A and impurity C.The impurity contents had far exceeded the acceptable limits specified by the quality standard.It was suggested that when taking the 1 sustained-release tablets,alcohol consumption should be prohibited in order to avoid increasing unknown safety risks due to excessive impurities.

dose dumpingdegradationgliclazide sustained-release tabletin vitro release

刘梦婷、孙国祥

展开 >

沈阳药科大学药学院,辽宁沈阳 110016

华夏生生药业(北京)有限公司,北京 102600

剂量倾泻 降解 格列齐特缓释片 体外释放

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(4)
  • 14